Newstral
Article
Mmcclatchydc.com on 2020-03-23 23:18
Coronavirus pneumonia drug possible ‘by summer’ after FDA fast-tracks clinical trial
Related news
- FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trialsjdsupra.com
- FDA approves first smart pill that tracks drug regimen compliance from the insidenewatlas.com
- FDA lifts clinical hold on AstraZeneca cancer drug studiesbizjournals.com
- FDA approves remdesivir as first coronavirus drugPOLITICO
- FDA allows emergency use of drug for coronavirusstaradvertiser.com
- Fact check: Trump falsely claims FDA approval for coronavirus drugtimesofisrael.com
- KZelensky-Trump meeting possible in late summerKyivPost
- FDA allows emergency use of antibody drug President Trump receivedDenver Post
- FDA allows emergency use of antibody drug Trump receivedbangordailynews.com
- EFDA recalls another blood pressure drug for possible cancer riskeu.usatoday.com
- EBlood pressure drug recalled for possible cancer risk, FDA sayseu.usatoday.com
- FDA Expresses Priorities for Clinical Trial Efficiency, Artificial Intelligencejdsupra.com
- Updated FDA COVID-19 Guidance for Conduct of Clinical Trialsjdsupra.com
- FDA Issues Guidance on Clinical Trials During COVID-19 Pandemicjdsupra.com
- First COVID-19 drug treatment gains FDA approvalalmanacnews.com
- South Dakota to Launch Hydroxychloroquine Clinical Trial for Possible Coronavirus Treatmentbreitbart.com
- FDA to Fast-Track Clinical Trials for Coronavirus Therapieswsj.com
- FDA authorizes emergency use of coronavirus drug remdesivirPOLITICO
- FDA approves first COVID-19 drug: antiviral remdesivirThe Fresno Bee